Prime Biosciences was founded in 2018 and offers a wide range of services in health care in Greece. The company has established relationships with both private and public hospitals and laboratories as well as a broad customer base of e.g. pediatricians and neonatologists.

“It feels great to launch our product in Greece where there is a great need for point-of-care diagnostics. Calmark Neo enables testing of children even when they are on any of the many islands”, says Magdalena Tharaldsen, Director International Business Development for Calmark. "I look forward to a rewarding collaboration with this committed distributor!"

This information is information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 31 May 2022, 09:20 CEST.

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

‍